Autoantibodies
Cross-source consensus on Autoantibodies from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Risks & contraindications
Evidence quality
Other
Highlighted claims
- Autoantibodies may appear years to decades before clinical autoimmune disease manifests. — Systems Immunology and Precision Medicine: Lymphocyte Testing for Personalized Care
- COVID-19 patient serum reacted with 25 of 80 tissue antigens involved in autoimmune disorders. — Systems Immunology and Precision Medicine: Lymphocyte Testing for Personalized Care
- Higher cardiolipin and platelet glycoprotein antibody levels were associated with more severe COVID-19 clinical presentation. — Systems Immunology and Precision Medicine: Lymphocyte Testing for Personalized Care
- Autoantibodies in blood do not necessarily mean a patient currently has autoimmune disease. — Systems Immunology and Precision Medicine: Lymphocyte Testing for Personalized Care
- Autoantibodies can identify at-risk individuals, support disease sub-phenotyping, inform prognosis, and guide individualized treatment. — Systems Immunology and Precision Medicine: Lymphocyte Testing for Personalized Care
- Older individuals had higher antibody levels in the COVID-19 systems biology analysis. — Systems Immunology and Precision Medicine: Lymphocyte Testing for Personalized Care